CSL receives positive opinion for garadacimab in hereditary angioedema - PharmaTimes New treatment could revolutionise care for HAE patients

#CSL #CSLBehring #garadacimab #hereditaryangioedema #HAE #HAEpatients #EMA #CHMP #factorXIIainhibitor #HAEattacks #CHMPdecision #HAEattacks #HAEattackprevention #Phase3clinicaltrial #VANGUARDclinicaltrial #openlabelextensionstudy
pharmatimes.com/news/csl-rec...